Related Experiment Video
Updated: Aug 19, 2026
Colorectal Cancer Cell Surface Protein Profiling Using an Antibody Microarray and Fluorescence Multiplexing
Published on: September 25, 2011
Do Indigenous patients in Australia's Northern Territory present with more advanced colorectal cancer? A cohort study
David J Read1,2, Ian Hayes2,3
1National Critical Care and Trauma Response Centre, Royal Darwin Hospital, Darwin, Northern Territory, Australia.
Background:
Previous studies show that Indigenous Australians (IndA) of the Northern Territory (NT) present later and have lower survival for colorectal cancer (CRC) compared with non-Indigenous (NI) Territorians. This study compared the odds of presenting with advanced-stage CRC between IndA and NI adjusted for demographic, histopathological and surgical features.
Methods:
A cohort study of NT Cancer Registry (NTCR) CRC cases from 2005 to 2014. All (667) persons notified to the NTCR with a new diagnosis of CRC were included, of which 504 had sufficient data for analysis. The NTCR was used for case identification and linked to available hospital clinical data. The principal exposure was IndA compared with NI and the principal outcome was odds of presenting with advanced-stage tumour (III and IV) compared with early-stage (I and II). Univariable and multivariable logistic regression were performed on all relevant variables.
Results:
Univariable logistic regression found no difference in the odds of advanced CRC between IndA and NI (odds ratio (OR) 0.99, 95% confidence interval (CI) 0.56-1.76, P = 0.982). This effect remained insignificant adjusted for the effects of sex, tumour position, remoteness and time period (OR 0.85, 95% CI 0.47-1.55, P = 0.606) and when adjusted for tumour grade, lympho-vascular invasion, lymph node harvest and emergency status (OR 1.39, 95% CI 0.64-3.03, P = 0.401).
Conclusions:
In distinction from previous studies, there was no evidence that IndA of the NT presented with later stage CRC in 2005-2014. Other factors (incomplete treatment or comorbidity) may be responsible for the continued observed survival disparity.
